Cargando…
Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia
Human microglia, as innate immune cells of the central nervous system (CNS), play a central role in the pathogenesis of a large number of neurological and psychiatric disorders. However, experimental access to primary human microglia for biomedical applications such as disease modeling is extremely...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902330/ https://www.ncbi.nlm.nih.gov/pubmed/35971018 http://dx.doi.org/10.1007/s12015-022-10433-w |
_version_ | 1784883236433821696 |
---|---|
author | Mathews, Mona Wißfeld, Jannis Flitsch, Lea Jessica Shahraz, Anahita Semkova, Vesselina Breitkreuz, Yannik Neumann, Harald Brüstle, Oliver |
author_facet | Mathews, Mona Wißfeld, Jannis Flitsch, Lea Jessica Shahraz, Anahita Semkova, Vesselina Breitkreuz, Yannik Neumann, Harald Brüstle, Oliver |
author_sort | Mathews, Mona |
collection | PubMed |
description | Human microglia, as innate immune cells of the central nervous system (CNS), play a central role in the pathogenesis of a large number of neurological and psychiatric disorders. However, experimental access to primary human microglia for biomedical applications such as disease modeling is extremely limited. While induced pluripotent stem cells (iPSCs) could provide an alternative source of microglia, the reenactment of their complex ontogenesis with a yolk sac origin and subsequent priming upon CNS invasion has remained a challenge. Here, we report a developmentally informed in vitro differentiation method for large-scale production and cryopreservation of iPSC-derived microglia (iPSdMiG). Specifically, iPSCs were propagated in conditions yielding both yolk sac hematopoietic derivatives and early neuroepithelial cells. To enable large-scale production, we implemented 3D bioreactor-based dynamic culture conditions and the use of novel mesh macrocarriers. Under these conditions, microglia could be harvested across a time period of at least 6 weeks, with 1 × 10(6) iPSCs giving rise to up to 45 × 10(6) iPSdMiG. The transcriptomic profile of iPSdMiG showed high similarity to adult human microglia, and harvested cells were immunopositive for typical microglial markers. In addition, iPSdMiG were able to secrete pro-inflammatory cytokines, engaged in phagocytotic activity, produced reactive oxygen species and lent themselves to co-culture studies in neural 2D and 3D systems. Importantly, iPSdMiG were efficiently cryopreserved, enabling the establishment of donor-specific microglia cell banks for disease modeling, drug discovery and eventually cell therapy. GRAPHICAL ABSTRACT: Main points. Scalable generation of iPSC-derived multi-lineage embryoid bodies on macrocarriers, reproducibly releasing microglia exhibiting characteristic markers and function. Cells are transcriptomically similar to primary human microglia and cryopreservable. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12015-022-10433-w. |
format | Online Article Text |
id | pubmed-9902330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-99023302023-02-08 Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia Mathews, Mona Wißfeld, Jannis Flitsch, Lea Jessica Shahraz, Anahita Semkova, Vesselina Breitkreuz, Yannik Neumann, Harald Brüstle, Oliver Stem Cell Rev Rep Article Human microglia, as innate immune cells of the central nervous system (CNS), play a central role in the pathogenesis of a large number of neurological and psychiatric disorders. However, experimental access to primary human microglia for biomedical applications such as disease modeling is extremely limited. While induced pluripotent stem cells (iPSCs) could provide an alternative source of microglia, the reenactment of their complex ontogenesis with a yolk sac origin and subsequent priming upon CNS invasion has remained a challenge. Here, we report a developmentally informed in vitro differentiation method for large-scale production and cryopreservation of iPSC-derived microglia (iPSdMiG). Specifically, iPSCs were propagated in conditions yielding both yolk sac hematopoietic derivatives and early neuroepithelial cells. To enable large-scale production, we implemented 3D bioreactor-based dynamic culture conditions and the use of novel mesh macrocarriers. Under these conditions, microglia could be harvested across a time period of at least 6 weeks, with 1 × 10(6) iPSCs giving rise to up to 45 × 10(6) iPSdMiG. The transcriptomic profile of iPSdMiG showed high similarity to adult human microglia, and harvested cells were immunopositive for typical microglial markers. In addition, iPSdMiG were able to secrete pro-inflammatory cytokines, engaged in phagocytotic activity, produced reactive oxygen species and lent themselves to co-culture studies in neural 2D and 3D systems. Importantly, iPSdMiG were efficiently cryopreserved, enabling the establishment of donor-specific microglia cell banks for disease modeling, drug discovery and eventually cell therapy. GRAPHICAL ABSTRACT: Main points. Scalable generation of iPSC-derived multi-lineage embryoid bodies on macrocarriers, reproducibly releasing microglia exhibiting characteristic markers and function. Cells are transcriptomically similar to primary human microglia and cryopreservable. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12015-022-10433-w. Springer US 2022-08-15 2023 /pmc/articles/PMC9902330/ /pubmed/35971018 http://dx.doi.org/10.1007/s12015-022-10433-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Mathews, Mona Wißfeld, Jannis Flitsch, Lea Jessica Shahraz, Anahita Semkova, Vesselina Breitkreuz, Yannik Neumann, Harald Brüstle, Oliver Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia |
title | Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia |
title_full | Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia |
title_fullStr | Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia |
title_full_unstemmed | Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia |
title_short | Reenacting Neuroectodermal Exposure of Hematopoietic Progenitors Enables Scalable Production of Cryopreservable iPSC-Derived Human Microglia |
title_sort | reenacting neuroectodermal exposure of hematopoietic progenitors enables scalable production of cryopreservable ipsc-derived human microglia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902330/ https://www.ncbi.nlm.nih.gov/pubmed/35971018 http://dx.doi.org/10.1007/s12015-022-10433-w |
work_keys_str_mv | AT mathewsmona reenactingneuroectodermalexposureofhematopoieticprogenitorsenablesscalableproductionofcryopreservableipscderivedhumanmicroglia AT wißfeldjannis reenactingneuroectodermalexposureofhematopoieticprogenitorsenablesscalableproductionofcryopreservableipscderivedhumanmicroglia AT flitschleajessica reenactingneuroectodermalexposureofhematopoieticprogenitorsenablesscalableproductionofcryopreservableipscderivedhumanmicroglia AT shahrazanahita reenactingneuroectodermalexposureofhematopoieticprogenitorsenablesscalableproductionofcryopreservableipscderivedhumanmicroglia AT semkovavesselina reenactingneuroectodermalexposureofhematopoieticprogenitorsenablesscalableproductionofcryopreservableipscderivedhumanmicroglia AT breitkreuzyannik reenactingneuroectodermalexposureofhematopoieticprogenitorsenablesscalableproductionofcryopreservableipscderivedhumanmicroglia AT neumannharald reenactingneuroectodermalexposureofhematopoieticprogenitorsenablesscalableproductionofcryopreservableipscderivedhumanmicroglia AT brustleoliver reenactingneuroectodermalexposureofhematopoieticprogenitorsenablesscalableproductionofcryopreservableipscderivedhumanmicroglia |